a Abtrace, a healthcare technology startup created in 2018 with operations in Portugal and the United Kingdom, announced Thursday that it has successfully closed a €2.4 million loan.
“This funding will allow Abtrace to transform what is now a data-driven tool that monitors and automates compliance with clinical practice guidelines and avoids multiple doctor visits, into a smart platform that tracks a patient’s journey in primary care in real time, starting with Omar Naim Ahmed, Abtrace CEO, said, In a statement, managing and monitoring pre-existing cases for early detection of new diseases Minute News He has access.
This funding includes a €1.3 million round of capital led by Portuguese venture capital firm Faber, with participation from Ganexa Capital and funding from UK innovation agency INNOVATE-UK.
Abtrace uses data stored in electronic health records, along with artificial intelligence tools, to simplify and improve clinical decisions in primary care, according to the same release.
Read also: A unique portrait of Jane Austen made by her sister has been loaned to the museum
“Writer. Analyst. Avid travel maven. Devoted twitter guru. Unapologetic pop culture expert. General zombie enthusiast.”
